Cargando…

A defined subunit vaccine that protects against vector-borne visceral leishmaniasis

Vaccine development for vector-borne pathogens may be accelerated through the use of relevant challenge models, as has been the case for malaria. Because of the demonstrated biological importance of vector-derived molecules in establishing natural infections, incorporating natural challenge models i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duthie, Malcolm S., Pereira, Lais, Favila, Michelle, Hofmeyer, Kimberly A., Reed, S. Jim, Metangmo, Sonia, Townsend, Shannon, Laurance, John D., Picone, Alessandro, Misquith, Ayesha, Hossain, Faria, Ghosh, Prakash, Khan, Md Anik Ashfaq, Guderian, Jeffery, Bailor, H. Remy, Liang, Hong, Vergara, Julie, Oliveira, Fabiano, Howard, Randall F., Kamhawi, Shaden, Mondal, Dinesh, Coler, Rhea N., Valenzuela, Jesus G., Reed, Steven G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627294/ https://www.ncbi.nlm.nih.gov/pubmed/29263878 http://dx.doi.org/10.1038/s41541-017-0025-5

Ejemplares similares

Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis
por: Duthie, Malcolm S., et al.
Publicado: (2016)

From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE
por: Coler, Rhea N, et al.
Publicado: (2015)

Optimizing Immunization Strategies for the Induction of Antigen-Specific CD4 and CD8 T Cell Responses for Protection against Intracellular Parasites
por: Hofmeyer, Kimberly A., et al.
Publicado: (2016)

Coinfection With Trypanosoma brucei Confers Protection Against Cutaneous Leishmaniasis
por: Pereira, Lais, et al.
Publicado: (2018)

Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis
por: Cecílio, Pedro, et al.
Publicado: (2017)

The yin and yang of leishmaniasis control
por: Kamhawi, Shaden
Publicado: (2017)

Vector Saliva in Vaccines for Visceral Leishmaniasis: A Brief Encounter of High Consequence?
por: Kamhawi, Shaden, et al.
Publicado: (2014)

Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment
por: Hossain, Faria, et al.
Publicado: (2017)

Evaluation of diagnostic performance of rK28 ELISA using urine for diagnosis of visceral leishmaniasis
por: Ghosh, Prakash, et al.
Publicado: (2016)

Biomarkers for Zoonotic Visceral Leishmaniasis in Latin America
por: Brodskyn, Claudia I., et al.
Publicado: (2018)

Building Research and Development Capacity for Neglected Tropical Diseases Impacting Leishmaniasis in the Middle East and North Africa: A Case Study
por: Rafati, Sima, et al.
Publicado: (2015)

Protective Efficacy in a Hamster Model of a Multivalent Vaccine for Human Visceral Leishmaniasis (MuLeVaClin) Consisting of the KMP11, LEISH-F3+, and LJL143 Antigens in Virosomes, Plus GLA-SE Adjuvant
por: Fernández, Laura, et al.
Publicado: (2021)

Implicating bites from a leishmaniasis sand fly vector in the loss of tolerance in pemphigus
por: Marzouki, Soumaya, et al.
Publicado: (2020)

Comparative salivary gland transcriptomics of sandfly vectors of visceral leishmaniasis
por: Anderson, Jennifer M, et al.
Publicado: (2006)

A structure-function approach to optimizing TLR4 ligands for human vaccines
por: Carter, Darrick, et al.
Publicado: (2016)

Immunity to Distinct Sand Fly Salivary Proteins Primes the Anti-Leishmania Immune Response towards Protection or Exacerbation of Disease
por: Oliveira, Fabiano, et al.
Publicado: (2008)

Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
por: Coler, Rhea N., et al.
Publicado: (2011)

Leishmania HASP and SHERP Genes Are Required for In Vivo Differentiation, Parasite Transmission and Virulence Attenuation in the Host
por: Doehl, Johannes S. P., et al.
Publicado: (2017)

Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model
por: Baldwin, Susan L., et al.
Publicado: (2021)

Prevalence of Cutaneous Leishmaniasis in Districts of High and Low Endemicity in Mali
por: Traoré, Bourama, et al.
Publicado: (2016)

Relationship of Serum Antileishmanial Antibody With Development of Visceral Leishmaniasis, Post-kala-azar Dermal Leishmaniasis and Visceral Leishmaniasis Relapse
por: Mondal, Dinesh, et al.
Publicado: (2019)

Centrin-deficient Leishmania mexicana confers protection against Old World visceral leishmaniasis
por: Karmakar, Subir, et al.
Publicado: (2022)

Development of a Natural Model of Cutaneous Leishmaniasis: Powerful Effects of Vector Saliva and Saliva Preexposure on the Long-Term Outcome of Leishmania major Infection in the Mouse Ear Dermis
por: Belkaid, Yasmine, et al.
Publicado: (1998)

Correction: Prevalence of Cutaneous Leishmaniasis in Districts of High and Low Endemicity in Mali
por: Traoré, Bourama, et al.
Publicado: (2017)

Leishmaniasis Vaccines: Applications of RNA Technology and Targeted Clinical Trial Designs
por: Duthie, Malcolm S., et al.
Publicado: (2022)

A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7
por: Fox, Christopher B, et al.
Publicado: (2014)

Sand Fly Salivary Proteins Induce Strong Cellular Immunity in a Natural Reservoir of Visceral Leishmaniasis with Adverse Consequences for Leishmania
por: Collin, Nicolas, et al.
Publicado: (2009)

Structure of SALO, a leishmaniasis vaccine candidate from the sand fly Lutzomyia longipalpis
por: Asojo, Oluwatoyin A., et al.
Publicado: (2017)

Sequential blood meals augment vector infectiousness by promoting Leishmania replication and triggering amplification of metacyclics via a novel retroleptomonad developmental stage
por: Serafim, Tiago D., et al.
Publicado: (2018)

Leishmania infection induces a limited differential gene expression in the sand fly midgut
por: Coutinho-Abreu, Iliano V., et al.
Publicado: (2020)

Distinct gene expression patterns in vector-residing Leishmania infantum identify parasite stage-enriched markers
por: Coutinho-Abreu, Iliano V., et al.
Publicado: (2020)

KSAC, a Defined Leishmania Antigen, plus Adjuvant Protects against the Virulence of L. major Transmitted by Its Natural Vector Phlebotomus duboscqi
por: Gomes, Regis, et al.
Publicado: (2012)

High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis
por: de Oliveira, Fabrícia Alvisi, et al.
Publicado: (2013)

Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection
por: Baldwin, Susan L., et al.
Publicado: (2018)

Immunity to Sand Fly Salivary Protein LJM11 Modulates Host Response to Vector-Transmitted Leishmania Conferring Ulcer-Free Protection
por: Gomes, Regis, et al.
Publicado: (2012)

Characterization of the Early Inflammatory Infiltrate at the Feeding Site of Infected Sand Flies in Mice Protected from Vector-Transmitted Leishmania major by Exposure to Uninfected Bites
por: Teixeira, Clarissa, et al.
Publicado: (2014)

Delayed-Type Hypersensitivity to Sand Fly Saliva in Humans from a Leishmaniasis-Endemic Area of Mali Is T(H)1-Mediated and Persists to Midlife
por: Oliveira, Fabiano, et al.
Publicado: (2013)

Circulating Biomarkers of Immune Activation, Oxidative Stress and Inflammation Characterize Severe Canine Visceral Leishmaniasis
por: Solcà, Manuela S., et al.
Publicado: (2016)

Use of Recombinant Antigens for Sensitive Serodiagnosis of American Tegumentary Leishmaniasis Caused by Different Leishmania Species
por: Sato, Camila Massae, et al.
Publicado: (2017)

Leishmaniasis Vaccination: Targeting the Source of Infection
por: Reed, Steven G.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_n40ashu414dgjrjf783qttn8f8